Ready or Not

At his blog, Neuroskeptic says broad-scale commercial fetal genome testing is "likely to become possible in the next few years." While researchers have already scanned fetal genomes to detect chromosomal abnormalities like Down syndrome, "those diseases are just the low-hanging fruit at the tip of the iceberg," Neuroskeptic says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.